Boston Family Office’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,251
| Closed | -$354K | – | 263 |
|
|
2023
Q2 | $354K | Sell |
4,251
-3,024
| -42% | -$252K | 0.03% | 219 |
|
|
2023
Q1 | $554K | Sell |
7,275
-2,195
| -23% | -$167K | 0.04% | 183 |
|
|
2022
Q4 | $786K | Sell |
9,470
-11,364
| -55% | -$943K | 0.07% | 168 |
|
|
2022
Q3 | $1.65M | Sell |
20,834
-19,010
| -48% | -$1.51M | 0.15% | 115 |
|
|
2022
Q2 | $2.96M | Sell |
39,844
-48,074
| -55% | -$3.57M | 0.25% | 82 |
|
|
2022
Q1 | $7.9M | Buy |
87,918
+4,805
| +6% | +$432K | 0.56% | 54 |
|
|
2021
Q4 | $9.31M | Buy |
83,113
+9,587
| +13% | +$1.07M | 0.61% | 51 |
|
|
2021
Q3 | $9.24M | Buy |
73,526
+2,090
| +3% | +$263K | 0.67% | 46 |
|
|
2021
Q2 | $9.67M | Buy |
71,436
+7,173
| +11% | +$971K | 0.69% | 46 |
|
|
2021
Q1 | $8.51M | Buy |
64,263
+2,485
| +4% | +$329K | 0.64% | 52 |
|
|
2020
Q4 | $8.7M | Sell |
61,778
-924
| -1% | -$130K | 0.67% | 51 |
|
|
2020
Q3 | $6.99M | Sell |
62,702
-389
| -0.6% | -$43.3K | 0.63% | 48 |
|
|
2020
Q2 | $7.06M | Buy |
63,091
+3,182
| +5% | +$356K | 0.69% | 46 |
|
|
2020
Q1 | $4.64M | Buy |
59,909
+31
| +0.1% | +$2.4K | 0.55% | 53 |
|
|
2019
Q4 | $5.7M | Sell |
59,878
-2,450
| -4% | -$233K | 0.54% | 54 |
|
|
2019
Q3 | $4.75M | Sell |
62,328
-1,194
| -2% | -$91.1K | 0.49% | 57 |
|
|
2019
Q2 | $5.57M | Sell |
63,522
-1,298
| -2% | -$114K | 0.58% | 53 |
|
|
2019
Q1 | $5.87M | Buy |
64,820
+32,081
| +98% | +$2.9M | 0.63% | 52 |
|
|
2018
Q4 | $2.35M | Sell |
32,739
-3,267
| -9% | -$234K | 0.29% | 90 |
|
|
2018
Q3 | $3.45M | Buy |
36,006
+3,856
| +12% | +$370K | 0.36% | 83 |
|
|
2018
Q2 | $3.06M | Buy |
+32,150
| New | +$3.06M | 0.35% | 84 |
|